SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 80 filers reported holding SERES THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $820,704 | -50.3% | 1,133,625 | -46.8% | 0.00% | – |
Q1 2024 | $1,651,071 | -43.7% | 2,132,643 | +1.8% | 0.00% | – |
Q4 2023 | $2,931,973 | -38.0% | 2,094,039 | +5.4% | 0.00% | -100.0% |
Q3 2023 | $4,730,988 | -49.6% | 1,987,559 | +1.3% | 0.00% | 0.0% |
Q2 2023 | $9,394,909 | +1.3% | 1,961,358 | +19.9% | 0.00% | 0.0% |
Q1 2023 | $9,273,342 | +104024.7% | 1,635,509 | +2.8% | 0.00% | 0.0% |
Q4 2022 | $8,906 | -99.9% | 1,590,395 | +5.6% | 0.00% | 0.0% |
Q3 2022 | $9,671,000 | +131.4% | 1,506,494 | +23.6% | 0.00% | 0.0% |
Q2 2022 | $4,180,000 | -51.5% | 1,218,748 | +0.8% | 0.00% | 0.0% |
Q1 2022 | $8,610,000 | -16.5% | 1,209,317 | -2.3% | 0.00% | 0.0% |
Q4 2021 | $10,307,000 | +55.0% | 1,237,362 | +29.5% | 0.00% | 0.0% |
Q3 2021 | $6,649,000 | -74.8% | 955,344 | -13.6% | 0.00% | -75.0% |
Q2 2021 | $26,385,000 | +31.7% | 1,106,322 | +13.7% | 0.00% | +33.3% |
Q1 2021 | $20,034,000 | -7.7% | 973,044 | +9.8% | 0.00% | -25.0% |
Q4 2020 | $21,707,000 | -4.0% | 886,045 | +10.9% | 0.00% | 0.0% |
Q3 2020 | $22,623,000 | +544.0% | 799,134 | +8.3% | 0.00% | +300.0% |
Q2 2020 | $3,513,000 | +48.7% | 738,121 | +11.5% | 0.00% | 0.0% |
Q1 2020 | $2,362,000 | -44.9% | 661,718 | -46.7% | 0.00% | – |
Q4 2019 | $4,284,000 | +95.1% | 1,241,870 | +126.7% | 0.00% | -100.0% |
Q3 2019 | $2,196,000 | +48.0% | 547,862 | +18.8% | 0.00% | – |
Q2 2019 | $1,484,000 | -22.3% | 461,106 | +65.9% | 0.00% | – |
Q1 2019 | $1,909,000 | -11.1% | 277,957 | -41.6% | 0.00% | – |
Q4 2018 | $2,148,000 | +25.1% | 475,548 | +110.1% | 0.00% | – |
Q3 2018 | $1,717,000 | -11.8% | 226,298 | -0.0% | 0.00% | -100.0% |
Q2 2018 | $1,946,000 | +16.6% | 226,397 | -0.5% | 0.00% | 0.0% |
Q1 2018 | $1,669,000 | -21.4% | 227,522 | +8.7% | 0.00% | 0.0% |
Q4 2017 | $2,123,000 | -22.7% | 209,395 | +22.3% | 0.00% | 0.0% |
Q3 2017 | $2,747,000 | +42.9% | 171,282 | +0.7% | 0.00% | 0.0% |
Q2 2017 | $1,922,000 | +2.6% | 170,095 | +2.3% | 0.00% | 0.0% |
Q1 2017 | $1,874,000 | +20.4% | 166,325 | +5.8% | 0.00% | 0.0% |
Q4 2016 | $1,556,000 | -9.5% | 157,265 | +12.4% | 0.00% | 0.0% |
Q3 2016 | $1,719,000 | -34.2% | 139,945 | +55.6% | 0.00% | 0.0% |
Q2 2016 | $2,612,000 | +27.8% | 89,929 | +16.8% | 0.00% | 0.0% |
Q1 2016 | $2,044,000 | -22.4% | 76,975 | +2.5% | 0.00% | -50.0% |
Q4 2015 | $2,635,000 | +33.6% | 75,109 | +12.8% | 0.00% | +100.0% |
Q3 2015 | $1,973,000 | – | 66,582 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 23,117,045 | $148,411,000 | 6.25% |
Eversept Partners, LP | 1,935,825 | $12,427,997 | 1.08% |
Kynam Capital Management, LP | 772,820 | $4,962,000 | 1.05% |
SILVERARC CAPITAL MANAGEMENT, LLC | 366,493 | $2,353,000 | 0.80% |
Lion Point Capital, LP | 626,803 | $3,228,000 | 0.71% |
FEDERATED HERMES, INC. | 18,499,136 | $118,765,000 | 0.35% |
Knott David M Jr | 110,000 | $706,000 | 0.30% |
Atom Investors LP | 108,820 | $699,000 | 0.25% |
Ikarian Capital, LLC | 131,310 | $843,000 | 0.17% |
HARVARD MANAGEMENT CO INC | 131,847 | $846,000 | 0.10% |